Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 15;6(5):1028-1031.
doi: 10.1016/j.euf.2020.05.019. Epub 2020 Jun 5.

Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials

Alexandra Abrams-Downey  1 , Joseph Saabiye  2 , Monica Vidaurrazaga  2
Affiliations
Review

Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials

Alexandra Abrams-Downey et al. Eur Urol Focus. .
No abstract available

PubMed Disclaimer

References

    1. National Institutes of Health. NIAID strategic plan for COVID-19 research. Published 22 April 22, 2020. www.niaid.nih.gov/sites/default/files/NIAID-COVID-19-Strategic-Plan-2020....
    1. Wang M., Cao R., Zhang L. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269–271. - PMC - PubMed
    1. Biot C., Daher W., Chavain N. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006;49:2845–2849. - PubMed
    1. Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14:72–73. - PubMed
    1. Yao, X, Ye F., Zhang M., et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. In press. https://doi.org/10.1093/cid/ciaa237. - PMC - PubMed

MeSH terms